Document qawvVOJDgr9oLDwaZyXeKgqwK

To: From: Cc: Bcc: Received Date: Subject: Owen, David DE SC-CHSE-DO <david.owen@shell.com> Cagen, Stuart Z SCC-HSE <lO=SHELLlOU=MSXSCC/CN=RECI PI ENTS/CN=SC724012> 2004-03-2614:35:28 GMT RE: CF Issues I spoke with Mike about this on Wednesday and have drafted a BO and Benzene Shanghai document See attached. I know Mike has since made some refinements to the BO document (and perhaps benzene as well. Note the benzene document should also be reviewed by Patsy). Stuart Cagen Sell Chemical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 1407 Fax: +1 713241 3325 Other Tel: +1 8326463987 Email: stuart.cagen@shell.com Internet: http://www.shell.com/chemicals -----Original Message----- From: Owen, David DE SC-CHSE-DO Sent: Friday, March 26, 20048:30 AM To: Cagen, Stuart Z SCC-HSE Subject: CF Issues Stu, When Mike and I met with Susan, we developed a number of items and processes to capture what 'big' items are being worked on by CF HSE. The obvious such as VCCEP, HPV, REACH come up but so do a few big PBU subjects. including Butadiene. I have attached a template we are using and a couple of examples I have done. Will you have some time to help get this done for butadiene next week?? See you next week David File: S&R Descriptions BLANK.rtf (Compressed)>> File: SCALE.rtf (Compressed) David Owen File: NCP.doc (Compressed) Manager, Health and Environmental Sciences Shell Chemicals Limited Shell Centre, London SE1 7NA, United Kingdom Tel: +44 (0)207934 2288 Fax: +44 (0)207934 7627 Email: David.E.Owen@OPC.shell.com Internet: http://www.shell.com Attachments: SH ELL-MCCLU RG-064405 RE: Issue summary example SH ELL-MCCLU RG-064406